Pharmaceutical Development and Technology

Papers
(The H4-Index of Pharmaceutical Development and Technology is 16. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Solid lipid nanoparticles and nanostructured lipid carriers: a review of the methods of manufacture and routes of administration57
Nanotechnologies for intranasal drug delivery: an update of literature42
Sustained latanoprost release from PEGylated solid lipid nanoparticle-laden soft contact lens to treat glaucoma34
Mucoadhesive chitosan and thiolated chitosan nanoparticles containing alpha mangostin for possible Colon-targeted delivery31
Mucoadhesive polymeric films comprising polyvinyl alcohol, polyvinylpyrrolidone, and poloxamer 407 for pharmaceutical applications26
Application of plant-derived exosome-like nanoparticles in drug delivery22
An overview of PLGA in-situ forming implants based on solvent exchange technique: effect of formulation components and characterization22
Gelatin-methacryloyl hydrogel based in vitro blood–brain barrier model for studying breast cancer-associated brain metastasis21
The use of electronic tongue and sensory panel on taste evaluation of pediatric medicines: a systematic review20
pH-sensitive chitosan-deoxycholic acid/alginate nanoparticles for oral insulin delivery20
Pulmonary drug delivery with aerogels: engineering of alginate and alginate–hyaluronic acid microspheres20
Chitosan caged liposomes for improving oral bioavailability of rivaroxaban: in vitro and in vivo evaluation19
Silver nanoparticles obtained from Brazilian pepper extracts with synergistic anti-microbial effect: production, characterization, hydrogel formulation, cell viability, and in vitro efficacy19
Recent advances in targeting malaria with nanotechnology-based drug carriers19
An evaluation of tocotrienol ethosomes for transdermal delivery using Strat-M® membrane and excised human skin18
Dry powder inhalation formulation of chitosan nanoparticles for co-administration of isoniazid and pyrazinamide17
Acriflavine-loaded solid lipid nanoparticles: preparation, physicochemical characterization, and anti-proliferative properties16
0.025825023651123